Disease Overview：Dacryocystitis（DC）
Dacryocystitis is an inflammatory condition of the lacrimal sac, typically caused by obstruction of the nasolacrimal duct leading to bacterial infection—most commonly *Staphylococcus aureus*, *Streptococcus pneumoniae*, or *Haemophilus influenzae*. Acute dacryocystitis presents with localized pain, swelling, erythema, and purulent discharge at the medial canthus; chronic cases may manifest as persistent epiphora and recurrent mild inflammation. If left untreated, complications such as orbital cellulitis, abscess formation, or systemic sepsis can occur. Diagnosis relies on clinical evaluation, lacrimal irrigation (syringing), imaging—including dacryocystography or CT dacryocystography—and microbiological culture when indicated. First-line management includes systemic antibiotics and warm compresses; definitive treatment often requires surgical intervention, most frequently endoscopic dacryocystorhinostomy (DCR), which creates a new drainage pathway between the lacrimal sac and nasal cavity.
China offers distinct advantages for international patients seeking high-quality dacryocystitis care. Leading ophthalmic centers in Beijing, Shanghai, and Guangzhou employ board-certified oculoplastic surgeons with extensive experience in minimally invasive endoscopic and laser-assisted DCR procedures. State-of-the-art intraoperative navigation systems, high-resolution endoscopes, and intraoperative optical coherence tomography enhance precision and reduce revision rates. Clinical outcomes align with global benchmarks: over 92% anatomical success and >88% functional success at one year, supported by published case series from tertiary hospitals. Treatment costs in China are typically 40–60% lower than in the US, UK, or Germany—even accounting for travel—without compromising safety or efficacy.
As a dedicated medical tourism agency, we facilitate seamless access to these services: pre-arrival consultation, verified hospital referrals, transparent all-inclusive pricing (covering surgery, diagnostics, accommodation, and interpreter support), and end-to-end coordination—from visa assistance to postoperative follow-up via telemedicine.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Dacryocystitis (Lacrimal Sac Inflammation)
Non-Surgical / Conservative Management
*Indicated for acute, mild-to-moderate cases without abscess formation or systemic toxicity.*
- •Topical Antibiotics (e.g., levofloxacin ophthalmic solution): ¥45–¥80 ($6–$11) per bottle
- •Oral Antibiotics (e.g., amoxicillin-clavulanate 625 mg × 7 days): ¥90–¥160 ($12–$22)
- •Warm Compresses & Lacrimal Sac Massage: No direct cost; instruction included in outpatient visit
- •Outpatient Evaluation & Culture/Sensitivity Testing: ¥120–¥200 ($16–$27), includes slit-lamp exam, lacrimal irrigation, and bacterial culture
Surgical / Procedural Interventions
*Required for chronic/recurrent cases, dacryocele, or failure of medical therapy. Performed by Ophthalmology Department.*
- •Dacryocystorhinostomy (DCR) — *Gold standard*:
- *Endoscopic DCR* (preferred): ¥8,200–¥12,500 ($1,120–$1,710) - *External DCR*: ¥6,800–¥9,400 ($930–$1,290)
- •Preoperative Workup (mandatory): Nasolacrimal endoscopy + CT dacryocystography + blood tests (CBC, coagulation, ECG): ¥1,450–¥2,100 ($200–$290)
- •Probing & Irrigation under Anesthesia (for infants <12 months): ¥1,800–¥2,600 ($250–$360), includes sedation
Special/Complex Condition Management
- •Acute Suppurative Dacryocystitis with Abscess: Incision & drainage + IV antibiotics (3-day inpatient stay): ¥4,900–¥7,300 ($670–$1,000), includes ICU-level monitoring if needed
- •Post-Traumatic or Post-Radiation Dacryocystitis: Requires custom silicone intubation + adjunctive mitomycin C: ¥10,800–¥14,200 ($1,480–$1,940)
- •Recurrent DCR Failure (>2 procedures): Endoscopic revision + conjunctivodacryocystorhinostomy (CDCR) with Jones tube: ¥13,500–¥17,600 ($1,850–$2,410)
Quick Selection Guide
- •Infants (<1 yr): Start with probing under anesthesia ($250–$360) — high success rate (>90%), lowest risk.
- •Adults, Mild Acute Episode: Oral + topical antibiotics + warm compresses ($18–$33 total) — avoid surgery unless recurrence.
- •Chronic (>6 mo), Working-Age Adult: Endoscopic DCR ($1,120–$1,710) — superior cosmesis, faster recovery, lower revision rate.
- •Elderly (>75 yr) or High-Risk Comorbidities (COPD, anticoagulation): External DCR ($930–$1,290) — more predictable anatomy, easier intraoperative control.
- •Budget-Constrained Patients: External DCR at public Grade 3A hospital ($930) — same long-term efficacy as endoscopic, lower facility fee.
- •Recurrent/Complex Cases: CDCR with Jones tube ($1,850–$2,410) — definitive solution when standard DCR fails due to severe scarring or canalicular loss.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Dacryocystitis Medical Vacation Packages
Curated transparent all-inclusive packages combining Dacryocystitis treatment with China top medical destinations:
